Mukherjee Raju, Chatterji Dipankar
Molecular Biophysics Unit, Indian Institute of Science, Malleswaram, Bangalore 560012, India.
Biochem Biophys Res Commun. 2008 May 9;369(3):899-904. doi: 10.1016/j.bbrc.2008.02.118. Epub 2008 Mar 6.
Rapid emergence of multi-drug resistance in Mycobacterium tuberculosis has necessitated the development of newer candidate drugs which can selectively inhibit the growth of the organism. Among the best targets available today, transcription machinery is, by far, the most important one and the antibiotic rifampicin binds to a specific site on the enzyme RNA polymerase. However, it is not very effective towards the stationary phase of the organism or the persistors. In order to address this problem, we report here a protocol for generating an affinity tagged RNA polymerase, which can be purified easily from different phases of growth of the organism. It allows exploring RNAP associated proteins, which may confer resistance to rifampicin, using the approach of functional proteomics.
结核分枝杆菌中多药耐药性的迅速出现使得开发能够选择性抑制该生物体生长的新型候选药物成为必要。在目前可用的最佳靶点中,转录机制是迄今为止最重要的靶点,抗生素利福平与酶RNA聚合酶上的一个特定位点结合。然而,它对该生物体的稳定期或持留菌效果不佳。为了解决这个问题,我们在此报告一种生成亲和标签RNA聚合酶的方案,该酶可从该生物体生长的不同阶段轻松纯化。它允许使用功能蛋白质组学方法探索可能赋予对利福平耐药性的RNA聚合酶相关蛋白。